You searched for "blind"
Comparison of the efficacy of anti-VEGFs agents in nvAMD
This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...
Perspectives on sustainability in ophthalmology
This was a prospective study of a multi-item survey aimed to assess and analyse patients’ perception of sustainability and the role of healthcare in general, and ophthalmology in particular. Levels of agreement were measured using a Likert scale. 105 patients...Newmedica welcomes GIRFT glaucoma guidance but calls for equitable commissioning to protect patient access
Newmedica has welcomed the publication of NHS England’s Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services, recognising it as an important step toward improving consistency and outcomes for patients across England. The guidance’s emphasis on patient...Glaucoma UK appoints Professor Cecilia Fenerty as new Chair of Trustees
Glaucoma UK has appointed Professor Cecilia Fenerty as its new Chair of Trustees following the charity’s Annual General Meeting in March 2026. Professor Fenerty succeeds Professor Anthony King, who stepped down after completing four years as Chair and nine years...Visit Surgitrac Instruments at ESCRS 2026 | Hall B, Booth B.339
The countdown is on for the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), taking place from 11–15 September 2026 at ExCeL London. As one of Europe's leading ophthalmic events, ESCRS brings together surgeons, theatre teams,...Heidelberg Engineering announces expansion of market access for digital surgical visualization platform
Heidelberg Engineering today announced the upcoming commercialization of Heidelberg OPERA®*, its fully digital surgical visualisation platform, which will be introduced through the company’s global sales force and distribution network. Heidelberg OPERA® is centred around a fully digital surgical microscope which...
Two-year GATHER2 data: anatomical gains, functional questions for avacincaptad pegol in geographic atrophy
Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) remains a leading cause of irreversible central vision loss, and complement dysregulation has long been implicated in its pathogenesis. In 2023, the US FDA approved the first two GA therapies, both...
Elevated anxiety levels in central serous chorioretinopathy
This prospective cross-sectional case-control, questionnaire-based study was aimed to compare association of anxiety disorder in patients with central serous chorioretinopathy (CSCR) and age-gender-matched healthy controls. Participants in the age group of 18–55 years were divided into 2 groups. Group A...
